Biotech - SiliconSnark

SiliconSnark robot juggles a notebook, laptop, and iced coffee in an imagined Cambridge AI office.

Boston Tech

Anthropic’s Boston Office Could Tackle Science, Software, and the Final Boss: Dunkin’

What could Anthropic work on in its Boston office? A snarky look at science, software, and AI safety—with plausible ideas clearly separated from confirmed plans.

SiliconSnark robot welcomes an AI office to Kendall Square as scientists inspect research methods around a conference table.

Boston Tech

Anthropic Expands in Boston. Kendall Square Would Like to See the Methods Section.

Anthropic’s Cambridge expansion gives Boston’s innovation economy a timely opening. The payoff depends on research, local startups, and more than office space.

SiliconSnark robot examines six aging clocks and a glass lung model in a Cambridge laboratory.

Boston Tech

Insilico’s Rentosertib Made Six Aging Clocks Blink. Boston Would Like the Receipts.

Insilico’s rentosertib study links an AI-designed lung drug to lower aging-clock estimates, with Boston researchers and important limits on the findings.

SiliconSnark robot routes MC4R signals through a switchboard in a Boston biotech lab.

Boston Tech

Superluminal Medicines Raised $60 Million to Make an Appetite Switch Pick a Lane

Boston biotech Superluminal Medicines raised $60 million to take an AI-designed oral drug for rare genetic obesity into its first human trial.

SiliconSnark robot replays sensor data from a laboratory experiment in Cambridge.

Boston Tech

Transfyr Raised $25 Million to Give Lab Experiments a Replay Button

Cambridge startup Transfyr raised $25 million to turn lab work into machine-readable data for reproducibility, training, and scientific automation.

Startups

Five Maine Tech Startups You Haven’t Heard Of. Fish Blood Is Involved.

Meet five Maine tech startups building industrial software, smart energy plugs, fish-blood biotech, seaweed plastics and water-monitoring buoys.

SiliconSnark robot studies a personalized mRNA cancer treatment in a Cambridge lab.

Boston Tech

Moderna’s Cancer Vaccine Finally Got Its Big Phase 3 Moment. The Footnotes Are Still in Cambridge.

Moderna and Merck say their personalized mRNA cancer vaccine met Phase 3 melanoma endpoints. The Cambridge biotech has a real win, with caveats.

SiliconSnark robot oversees automated biotech sample freezers near Boston and Route 128.

Boston Tech

Azenta Grew 12% by Making Biotech’s Freezers and Sequencers Less Boring

Burlington’s Azenta grew 12% in Q3 as biotech demand lifted sample management and multiomics, but quality costs keep the turnaround honest.

SiliconSnark robot guides glowing gene editors through a Boston-shaped blood-vessel model.

Boston Tech

Mass General Got $25.8 Million to Send Gene Editors Into Blood Vessels

Mass General won up to $25.8 million from ARPA-H to build a reusable gene-editing platform for rare vascular diseases in Boston and beyond for patients.

SiliconSnark robot in Kendall Square beside a giant CPAP mask and an AD109 pill heading toward FDA review.

Boston Tech

Apnimed Got Its Sleep Apnea Pill Into FDA Review, and Cambridge Sees a CPAP Exit Ramp

Apnimed's July 14 FDA filing acceptance puts its Cambridge sleep apnea pill AD109 on track for a February 28, 2027 review decision.

SiliconSnark robot outside a Cambridge biotech office juggling an antibiotic bottle, antibodies, and financing papers.

Boston Tech

Spero Turned an Antibiotic Approval Into an Immunology Pivot, Because Cambridge Never Wastes a Receipt

Spero Therapeutics used a $105 million royalty financing and a new antibody license to turn its Utebzi approval into a Cambridge immunology reboot.

SiliconSnark robot outside Biogen in Cambridge with a giant autoinjector and home-treatment imagery.

Boston Tech

Biogen Got an At-Home Leqembi Start Approved, and Cambridge Just Shortened the Infusion Pilgrimage

FDA approved Leqembi IQLIK's at-home starting dose on July 13, giving Cambridge-based Biogen a meaningful Alzheimer's access and workflow win.

See all